Leerink Partners Reiterates Outperform Rating on CVS Health (CVS), partnership with Google Cloud "positive AI development"
Tweet Send to a Friend
Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $98.00 price target on CVS Health (NYSE: CVS)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
